2Hoieggen A,Alderman MH,Kjeldsen SE,et al. The impact of serum uric acid on cardiovascular outcomes in the LIFE study [J]. Kidney Int,2004,65(3) :1041-1049.
3Fang J, Alderman MH. Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971 -- 1992. National Health and Nutrition Examination Survey[J]. JAMA, 2000,283(18) :2404-2410.
4Viazzi F, Parodi D, Leoncini G, et al. Serum uric acid and target organ damage in primary hypertension [J]. Hypertension, 2005,45(5) :991-996.
5Culleton BF, Larson MG, Wilson PW, et al. Cardiovascular disease and mortality in a community-based cohort with mild renal insu fficieney[J].Kidney Int, 1999,56 ( 6 ) : 2214-2219.
6Johnson RJ, Kang DH, Feig D, et al. Is there a pathogenetie role for uric acid in hypertension and cardiovascular and renal d sease? [J]. Hypertension,2003,41(6) : 1183-1190.
7Weir CJ, Muir SW, Waiters MR, et al. Serum urate as an independent predictor of poor outcome and future vascular events after acute stroke[J]. Stroke,2003,34(8): 1951-1956.
8Puig JG,Ruilope LM. Uric acid as a cardiovascular risk factor in arterial hypertension[J]. J Hypertens, 1999,17 (7) : 869-872.
9Alderman MH, Cohen H, Madhavan S, et al. Serum uric acid and cardiovascular events in successfully treated hypertensive patients[J]. Hypertension, 1999,34( 1 ): 144-150.
二级参考文献6
1Fang J, Alderman MH. Serum uric acid and cardiovascular mortality: the NHANES I Epidemiologic Follow-up Study, 1971- 1992. JAMA,2000,283 : 2404-2410.
2Viazzi F, Parodi D, Leoncini G, et al. Serum uric acid and target organ damage in primary hypertension. Hypertension, 2005,45 : 991- 996.
3Culleton BF, Larson MG, Wilson PW, et al. Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency. Kidney Int, 1999,56:2214-2219.
4Johnson RJ, Kang DH, Feig D,et al. Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension,2003,41 : 1183-1190.
52007 Guidelines for the Management of Arterial Hypertension. The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology ( ESC ). J Hypertens, 2007, 25 : 1105-1187.
6Hoieggen A, Alderman MH, Kjeldsen SE, et al. The impact of serum uric acid on cardiovascular outcomes in the LIFE study. Kidney Int ,2004,65 : 1041-1049.
